NCCN Guidelines Version 3.2022
- MDS/MPN Overlap Neoplasms
- Myelodysplastic Syndromes
NCCN Guidelines with Evidence Blocks Version 3.2022
Myelodysplastic Syndromes-English Version 2021
Myelodysplastic Syndromes-Spanish Version 2021
Myelodysplastic Syndromes-Spanish - Latin America Version 2021
Calendar of Events
Continuing Education
NCCN Guidelines® Insights - Myelodysplastic Syndromes, Version 3.2022
Translations
Spanish (Latin America) Version 3.2022
Disclosure Policy
Panel Member Disclosures
Panel Member Disclosures by Meeting Date
End User License Agreement